|
|
Other links at Articles > Rheumatology |
| 3. |
Syk Kinase Inhibitor Rapidly Reduces Disease Activity in RA
|
|
|
A new class of oral drugs for treatment of rheumatoid arthritis -- Syk kinase inhibitors -- produces a rapid reduction in disease activity, according to results of a phase II trial presented Monday at the American College of Rheumatology Annual Scientific Meeting in San Francisco. Reuters Health Information
|
| 4. |
Rituximab May Be an Option for Refractory Polymyositis
|
|
|
Rituximab is safe and may be effective for adult patients with active polymyositis who are refractory to corticosteroids and at least two other immunosuppressive agents, clinicians from China conclude based on results of an open-label prospective study reported in the Journal of Rheumatology for September. Reuters Health Information
|
|
|
